Not applicableStudy completedNCT00210951
What this trial is testing
Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin
Who this might be right for
Red-Cell Aplasia, PureChronic Renal Failure
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4,761